2014
DOI: 10.2217/nnm.13.154
|View full text |Cite
|
Sign up to set email alerts
|

Rifampicin-Loaded ‘Flower-Like’ Polymeric Micelles for Enhanced Oral Bioavailability in An Extemporaneous Liquid Fixed-Dose Combination with Isoniazid

Abstract: Overall results highlight the potential of this nanotechnology platform to develop an extemporaneous liquid RIF/INH fixed-dose combination suitable for pediatric administration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
17
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 41 publications
(19 citation statements)
references
References 48 publications
2
17
0
Order By: Relevance
“…Thereafter the improvement on AUC 0-24 values for the micellar systems could be related with the ability of the NFV-loaded nanocarrier (D h : 5.6 nm) to diffuse though the mucus barrier, reaching the intestinal mucosa and promoting NFV absorption. These results are in good concordance with previously investigations where an enhanced oral bioavailability of a poorly-water soluble drug was observed after its encapsulation within nano-sized micelles [39,[41][42][43]. Interestingly, TPGS has been reported as a potent inhibitor of P-gp [22] and NFV results a P-gp substrate as other IP drugs [11,14].…”
Section: Nfv Oral Pharmacokineticssupporting
confidence: 91%
See 2 more Smart Citations
“…Thereafter the improvement on AUC 0-24 values for the micellar systems could be related with the ability of the NFV-loaded nanocarrier (D h : 5.6 nm) to diffuse though the mucus barrier, reaching the intestinal mucosa and promoting NFV absorption. These results are in good concordance with previously investigations where an enhanced oral bioavailability of a poorly-water soluble drug was observed after its encapsulation within nano-sized micelles [39,[41][42][43]. Interestingly, TPGS has been reported as a potent inhibitor of P-gp [22] and NFV results a P-gp substrate as other IP drugs [11,14].…”
Section: Nfv Oral Pharmacokineticssupporting
confidence: 91%
“…The release from polymeric micelles is a complex process that involves different mechanisms such as diffusion of drug molecules, polymer chain relaxation and erosion [39]. In the present study, the mathematical analysis comprised the fitting to zero order, firstorder and Higuchi model.…”
Section: In Vitro Nfv Releasementioning
confidence: 99%
See 1 more Smart Citation
“…This amphiphilic BAB copolymer leads to micelles with a hydrophilic corona of looped PEG blocks, which confers on the system appearance of flower petals. Rifampicin-loaded micelles displayed a spherical morphology and remarkably increased drug solubility and stability in acid medium [116]. These micelles delayed the release of rifampicin for 2 --3 h and minimized the direct contact of rifampicin with the gastric medium, which led to improved bioavailability compared with a drug suspension [116].…”
Section: Mixed Micellesmentioning
confidence: 99%
“…Amorphous PLA might better integrate/disperse the drug within the polymer matrix. Flower-like polymeric micelles of poly("-caprolactone)-bpoly(ethylene glycol)-b-poly("-caprolactone) (PCL-b-PEG-b-PCL) have been shown suitable for encapsulation of rifampicin [115,116]. This amphiphilic BAB copolymer leads to micelles with a hydrophilic corona of looped PEG blocks, which confers on the system appearance of flower petals.…”
Section: Mixed Micellesmentioning
confidence: 99%